Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Previous postmortem and neuroimaging studies have repeatedly suggested alterations in serotonin 5-HT2A receptor (5-HT2AR) binding associated with the pathophysiology of schizophrenia. These studies were performed with ligands, such as ketanserin, altanserin and LSD, that may bind with high-affinity to different structural or functional conformations of the 5-HT2AR. Interpretation of results may also be confounded by chronic antipsychotic treatment and suicidal behavior in the schizophrenia group. We quantified 5-HT2AR density by radioligand binding assays in postmortem prefrontal cortex of antipsychotic-free (n=29) and antipsychotic-treated (n=16) schizophrenics, suicide victims with other psychiatric diagnoses (n=13), and individually matched controls. [3H]Ketanserin binding, and its displacement by altanserin or the LSD-like agonist DOI, was assayed. Results indicate that the number of [3H]ketanserin binding sites to the 5-HT2AR was increased in antipsychotic-free (128±11%), but not in antipsychotic-treated (92±12%), schizophrenic subjects. In suicide victims, [3H]ketanserin binding did not differ as compared to controls. Aging correlated negatively with [3H]ketanserin binding in schizophrenia, suicide victims and controls. The fraction of high-affinity sites of DOI displacing [3H]ketanserin binding to the 5-HT2AR was increased in antipsychotic-free schizophrenic subjects. Functional uncoupling of heterotrimeric G proteins led to increased fraction of high-affinity sites of altanserin displacing [3H]ketanserin binding to the 5-HT2AR in schizophrenic subjects, but not in controls. Together, these results suggest that the active conformation of the 5-HT2AR is up-regulated in prefrontal cortex of antipsychotic-free schizophrenic subjects, and may provide a pharmacological explanation for discordant findings previously obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 2×
“…psilocybin and lysergic acid diethylamide (LSD), produce in normal subjects symptom profiles comparable to those seen in acutely ill unmedicated or first-episode schizophrenics (Young, 1974; Hermle et al., 1992; Vollenweider et al., 1998; Gouzoulis-Mayfrank et al., 2005; Quednow et al., 2011).”
BackgroundMiyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · cited 1×
“Second generation, or atypical, antipsychotic drugs all have in common a high-affinity for the 5-HT2AR, and a lower affinity for the dopamine D2 receptor (Miyamoto et al., 2005).”
BackgroundIdentification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803
Self-citationFribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.055 · Cited by 311 · cited 5×
“…been involved in the symptoms of schizophrenia, and proposed to contribute to the molecular mechanisms by which atypical antipsychotic drugs, such as clozapine, olanzapine and risperidone, induce their clinical effects (Gonzalez-Maeso and Sealfon, 2009; Fribourg et al., 2011; Kurita et al., 2012).”
BackgroundSelf-citationHuot, P., Johnston, T. H., Darr, T., Hazrati, L., Visanji, N. P., Pires, D., Brotchie, J. M., & Fox, S. H. (2010) · Movement Disorders · doi:10.1002/mds.23083 · Cited by 153 · cited 2×
“…of 5-HT2AR in frontal cortex may be associated to psychotic symptoms in schizophrenia patients, hypothesis that is also supported by findings in postmortem temporal cortex of parkinsonian subjects with visual hallucinations treated with medications that were not antipsychotics (Huot et al., 2010).”
ResultHigher Postmortem Prefrontal 5-HT2A Receptor Binding Correlates with Lifetime Aggression in Suicide
Oquendo, M. A., Russo, S. A., Underwood, M. D., Kassir, S. A., Ellis, S. P., Mann, J. J., & Arango, V. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.037 · Cited by 96 · cited 2×
“Postmortem brain studies of suicide victims have suggested a relationship between 5-HT2AR density in frontal cortex and suicidal behavior (Oquendo et al., 2006).”
BackgroundA Phenomenological Comparison of LSD and Schizophrenic States
YOUNG, B. G. (1974) · The British Journal of Psychiatry · doi:10.1192/bjp.124.1.64 · Cited by 42 · cited 2×
“…psilocybin and lysergic acid diethylamide (LSD), produce in normal subjects symptom profiles comparable to those seen in acutely ill unmedicated or first-episode schizophrenics (Young, 1974; Hermle et al., 1992; Vollenweider et al., 1998; Gouzoulis-Mayfrank et al., 2005; Quednow et al., 2011).”
Background
Cited by
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
Self-citationPsilocybin – Summary of knowledge and new perspectives
Tylš, F., Páleníček, T., & Horáček, J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.006 · Cited by 276
Selvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.005 · Cited by 223
Cheah, S.-Y., Lawford, B., Young, R., Morris, C., & Voisey, J. (2017) · Genes · doi:10.3390/genes8010014 · Cited by 50
G Protein-Coupled Receptor Heterocomplexes in Neuropsychiatric Disorders
Moreno, J. L., Holloway, T., & González-Maeso, J. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-386931-9.00008-8 · Cited by 30
Self-citation
Metadata
- Authors
- Muguruza, C., Moreno, J. L., Umali, A., Callado, L. F., Meana, J. J., & González-Maeso, J.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 23
- Issue
- 8
- Pages
- 852-864
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2096400789
- Cited by
- 85
- References
- 7
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.